Citation Impact
Citing Papers
Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.
1985
Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register
2009
Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
2008
The disabilities of the arm, shoulder and hand (DASH) outcome questionnaire: longitudinal construct validity and measuring self-rated health change after surgery
2003 Standout
Antinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology
1989 Standout
Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study
2003
It's Good to Feel Better But It's Better To Feel Good and Even Better to Feel Good as Soon as Possible for as Long as Possible. Response Criteria and the Importance of Change at OMERACT 10: Figure 1.
2011
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
2006 Standout
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Rheumatoid arthritis
2018 Standout
The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
2008 Standout
Methods for assessing responsiveness
2000
Accelerated Systemic Autoimmunity in the Absence of Somatic Hypermutation in 564Igi: A Mouse Model of Systemic Lupus with Knocked-In Heavy and Light Chain Genes
2017 StandoutNobel
Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature
2004
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
2008 Standout
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: Results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)
2005
Autoimmunity and Bone
2006
Juvenile idiopathic arthritis
2007 Standout
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
2005 Standout
Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab
2002
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIII. Baseline predictors of vascular events
2004
The Epidemiology of low back pain
2010 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Female Bias in Systemic Lupus Erythematosus is Associated with the Differential Expression of X-Linked Toll-Like Receptor 8
2015
Skeletal remodeling in health and disease
2007 Standout
Mortality studies in psoriatic arthritis: Results from a single outpatient center. II. Prognostic indicators for death
1998
Health-related quality of life in older adults with symptomatic hip and knee osteoarthritis: a comparison with matched healthy controls
2005
Adalimumab for long‐term treatment of psoriatic arthritis: Forty‐eight week data from the adalimumab effectiveness in psoriatic arthritis trial
2007
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States
1998 Standout
A Conditional Markov Model for Clustered Progressive Multistate Processes under Incomplete Observation
2004
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
The Role of Knee Alignment in Disease Progression and Functional Decline in Knee Osteoarthritis
2001 Standout
SYSTEMIC LUPUS ERYTHEMATOSUS FLARES DURING PREGNANCY
1997
Psoriatic arthritis assessment tools in clinical trials
2005
Extrapituitary Prolactin: Distribution, Regulation, Functions, and Clinical Aspects*
1996
The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review
2011 Standout
Mortality studies in psoriatic arthritis. Results from a single outpatient clinic. I. Causes and risk of death
1997
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Natural history of psoriatic arthritis
1994
A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience
2003
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
2007 Standout
Adalimumab improves joint-related and skin-related functional impairment in patients with psoriatic arthritis: patient-reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial
2006
The use of methotrexate in childhood rheumatic diseases
1998
Altered bone remodeling in psoriatic arthritis
2008
A Pearson‐type goodness‐of‐fit test for stationary and time‐continuous Markov regression models
2002
Psoriatic arthritis
1995
Hospitalizations for coronary artery disease among patients with systemic lupus erythematosus
2003
Holistic analysis of the life course: Methodological challenges and new perspectives
2018 Standout
Therapy Insight: systemic lupus erythematosus as a risk factor for cardiovascular disease
2005
Etanercept
2002
Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis
2004
Crohn's disease clinical course and severity in obese patients
2002
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
Polymorphism of the β3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine
2003
Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial
2001 Standout
Determinants of Health-related Quality of Life in Adults with Congenital Heart Disease
2007
Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies
2008
Incidence and risk factors of thromboembolism in systemic lupus erythematosus: A comparison of three ethnic groups
2005
Release of cartilage and bone macromolecules into synovial fluid: differences between psoriatic arthritis and rheumatoid arthritis
2001
ASH evidence-based guidelines: should asymptomatic patients with antiphospholipid antibodies receive primary prophylaxis to prevent thrombosis?
2009
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
2006 Standout
A general goodness‐of‐fit test for Markov and hidden Markov models
2007
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Assessment of patients with psoriatic arthritis: A review of currently available measures
2004
Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort{
2002
Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.
2006
The Complex Role of Estrogens in Inflammation
2007 Standout
Clinical Aspects of the Spondyloarthropathies
1998
The family history of patients with primary or secondary antiphospholipid syndrome (APS)
2000
Sex hormones in the pathogenesis of systemic lupus erythematosus
2001
Psoriasis Pathogenesis and Treatment
2019 Standout
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Multi-State Models for Panel Data: ThemsmPackage forR
2011 Standout
Clinical features of psoriatic arthritis.
2002
V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose
2013 Standout
TNF‐mediated inflammatory disease
2007 Standout
Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety
2014
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices
2006
Neurodevelopmental Outcomes in Children With Congenital Heart Disease: Evaluation and Management
2012 Standout
Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors
2005
Treatment of Periodontitis and Endothelial Function
2007 Standout
Works of Gladman Dd being referenced
The utility of the arthritis impact measurement scales for patients with psoriatic arthritis.
1992
Reliability of measurements of active and damaged joints in psoriatic arthritis.
1990
Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study.
1998
Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis.
1998
Premature coronary artery disease in systemic lupus erythematosus in the absence of corticosteroid use.
2000
Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus
2008
Prolactin in systemic lupus erythematosus.
1994
A family study of the antiphospholipid syndrome associated with other autoimmune diseases.
1992
Methotrexate in systemic lupus erythematosus.
1994
Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus.
1999
Systemic lupus erythematosus in a patient with C4 deficiency.
1982
Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model.
1995
A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE)
1996
Followup in psoriatic arthritis: relationship to disease characteristics.
1992
Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic Arthritis.
1996